ArticleNPJ precision oncology2026

KIT Mutation-NTRK fusion oncogenic driver switch: a novel mechanism of acquired imatinib resistance in GIST.

Simona Gloazzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.